Cargando…
The Current Status of Allogenic Islet Cell Transplantation
Type 1 Diabetes (T1D) is an autoimmune destruction of pancreatic beta cells. The development of the Edmonton Protocol for islet transplantation in 2000 revolutionized T1D treatment and offered a glimpse at a cure for the disease. In 2022, the 20-year follow-up findings of islet cell transplantation...
Autores principales: | Czarnecka, Zofia, Dadheech, Nidheesh, Razavy, Haide, Pawlick, Rena, Shapiro, A. M. James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605704/ https://www.ncbi.nlm.nih.gov/pubmed/37887267 http://dx.doi.org/10.3390/cells12202423 |
Ejemplares similares
-
AT7867 promotes pancreatic progenitor differentiation of human iPSCs
por: Cuesta-Gomez, Nerea, et al.
Publicado: (2023) -
Pan-caspase inhibitor F573 mitigates liver ischemia reperfusion injury in a murine model
por: Bral, Mariusz, et al.
Publicado: (2019) -
Suspension culture improves iPSC expansion and pluripotency phenotype
por: Cuesta-Gomez, Nerea, et al.
Publicado: (2023) -
Improved islet recovery and efficacy through co-culture and co-transplantation of islets with human adipose-derived mesenchymal stem cells
por: Gamble, Anissa, et al.
Publicado: (2018) -
A Small Molecule Swertisin from Enicostemma littorale Differentiates NIH3T3 Cells into Islet-Like Clusters and Restores Normoglycemia upon Transplantation in Diabetic Balb/c Mice
por: Dadheech, Nidheesh, et al.
Publicado: (2013)